iBio
IBIO
IBIO
29 hedge funds and large institutions have $3.45M invested in iBio in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
22% less funds holding
Funds holding: 37 → 29 (-8)
62% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 13
Holders
29
Holding in Top 10
–
Calls
$1.32M
Puts
$773K
Top Buyers
| 1 | +$676K | |
| 2 | +$113K | |
| 3 | +$56.2K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$22.1K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$15.4K |
Top Sellers
| 1 | -$631K | |
| 2 | -$404K | |
| 3 | -$173K | |
| 4 |
BlackRock
New York
|
-$169K |
| 5 |
Millennium Management
New York
|
-$31K |